Neuroblastomas undergo spontaneous regression at an unusually high rate. The mechanisms are not clear, but apoptosis may be involved. A large proportion of neuroblastomas is characterized by ampli®cation of MYCN. Using human neuroblastoma cells harbouring tetracycline controlled expression of MYCN we have analysed the role of the MycN protein and IFNg in cell death decision. Neither conditional expression of MYCN nor treatment with IFNg alone was sucient to trigger cell death. However, when acting in concert MycN and IFNg eciently triggered cell death, which was accompanied by DNA fragmentation and required caspase activity, two hallmarks of apoptosis. MycN and IFNg may cooperate along at least two dierent pathways. First, IFNg increased the CD95 cell surface expression while MycN enhanced the cellular susceptibility for the CD95 mediated death signal. Second, IFNg treatment induced expression of BAK mRNA while MycN and IFNg in combination increased the amount of Bax protein, another activator of apoptosis, without a concomitant increase in BAX mRNA. MycN also increased cell death in response to TRAIL and TNFa, suggesting that enforced MYCN expression in general increases the susceptibility of neuroblastoma cells towards a variety of death stimuli.
Introduction
Neuroblastoma is a tumor of the sympathic nervous system developing in young children (Berthold, 1990; Schwab and Joshi, 1997) . A subset of neuroblastomas, often accompanied by ampli®cation of the MYCN gene (Schwab et al., 1995; Schwab, 1998) , causes high mortality despite extensive therapy. Other tumors mature spontaneously in vivo to more benign ganglioneuroblastomas or ganglioneuromas or resolve without treatment such as neuroblastoma in situ or neuroblastoma stage 4S, a unique clinical presentation of apparently metastatic disease in infants. The incidence of spontaneous regression is greater in neuroblastomas than in any other human tumor, and it has been suggested that programmed cell death could account for this clinical feature (Pritchard and Hickman, 1994) . In line with this, massive apoptosis has been detected in primary neuroblastoma (Ikeda et al., 1996) . Additionally, expression of the apoptosis blocking BCL2 in primary neuroblastoma was correlated with poor prognosis (Castle et al., 1993) , while high level expression of ICE and CPP32, two proteases participating in the execution of apoptosis, was associated with a favourable outcome (Nakagawara et al., 1997) .
Various cellular proteins have been discovered as participants in regulating apoptosis (for a review see White, 1996) . Among these are the closely related transcription factors c-Myc, found to trigger apoptosis in serum-deprived rat embryo ®broblasts and antigenstimulated T-lymphocytes (Askew et al., 1991; Evan et al., 1992; Shi et al., 1992 , for a review see Henriksson and LuÈ scher, 1996) and MycN observed to cause apoptosis in B-lymphocytes when expressed from the immunoglobulin enhancer Em in transgenic mice (ZoÈ rnig et al., 1995) . MycN accelerates cell cycle progression of neuroblastoma cells (Lutz et al., 1996) , and targeted expression of MYCN causes neuroblastoma in transgenic mice (Weiss et al., 1997) . However, in none of these systems a role of ectopic MYCN expression in apoptosis of neuroblastoma cells has been demonstrated.
Interferon-g (IFNg) inhibits proliferation and promotes dierentiation of neuroblastoma cells and has been proposed as an agent in a dierentiationbased therapy (Ponzoni et al., 1992) . Neuroblastoma cells respond to activation of the IFNg receptor not only with dierentiation but also with apoptosis (Montaldo et al., 1997) suggesting a potential for this cytokine as a therapeutic agent.
To study the eect of MycN and IFNg on neuroblastoma cells we used a human neuroblastoma cell line with conditional expression of MYCN (Lutz et al., 1996) . Induced MYCN alone was unable to trigger cell death in neuroblastoma cells. However, induction of MYCN in combination with IFNg treatment caused a dramatic increase in cell death. MycN and IFNg mediated cell death was accompanied by DNAfragmentation and required the activation of caspases. Cooperation between MycN and IFNg was observed at two levels. IFNg up-regulated the cell surface expression of CD95 (also termed Fas and Apo-1) while ectopic MYCN expression increased the susceptibility towards the CD95 mediated death signal. Previously, the CD95 system, one of the key ligand driven apoptosis pathways (for a review see Fraser and Evan, 1996) , has been implicated in apoptosis of neuroblastoma cells (Fulda et al., 1997) . The second level of cooperation was the apoptosis regulatory network of Bcl-2 related proteins, which either block (Bcl-2) or accelerate (Bak, Bax and Bad) cell death (Chittenden et al., 1995; Farrow et al., 1995; Kiefer et al., 1995 ; for a review see Kroemer, 1997) .
IFNg induced expression of BAK and, in combination with MycN, increased Bax protein levels thereby shifting the balance of Bcl-2 related proteins towards death promoting family members.
Results

MycN enhances IFNg triggered cell death
We have studied the ability of MYCN to induce apoptosis in neuroblastoma cells by using Tet-21/N cells, which are a derivative of the cell line SH-EP with tetracycline-controlled expression of MYCN (Lutz et al., 1996) . Near-con¯uent cultures of Tet-21/N were cultivated in the presence (MYCN expression o; MYCN
7
) and in the absence of tetracycline (MYCN expression on; MYCN + ) with a change of medium supplemented with 10% fetal calf serum every other day. Cell death was monitored by microscopic inspection. No signi®cant cell death was seen during an observation period of 10 days regardless of MYCN expression status ( Figure 1A ; and data not shown). The same result was obtained when cells were cultivated in serum-free medium, a condition that leads to apoptosis in rat ®broblasts overexpressing cmyc (not shown; Evan et al., 1992) . Only when con¯uent cultures were left without medium change for more than three days MYCN + cells responded with massive cell death, while MYCN 7 cells maintained an intact monolayer (not shown). We conclude that enforced MYCN expression alone is not sucient to trigger apoptosis of neuroblastoma cells even in the absence of growth factors.
To test whether MycN can in¯uence the cellular response to IFNg MYCN + and MYCN 7 cells were treated with 1000 U/ml of IFNg and monitored for cell death over a period of 5 days. A small fraction of cells treated with IFNg in the absence of MYCN expression underwent death within 48 h after addition of IFNg, but even after 5 days the majority of apparently unchanged cells adhered to the culture dish ( Figure 1A ; photographs b and f). In contrast, many of the MYCN + cells died within 48 h after addition of IFNg, and only a minor fraction remained attached to the culture dish after 5 days ( Figure 1A ; d and h).
DNA fragmentation, determined by agarose gel electrophoresis, was seen at a low level in cells either expressing MYCN or treated with IFNg, but to a much larger extent in cells expressing MYCN and simultaneously treated with IFNg (data not shown). To quantitate the extent of apoptosis after addition of IFNg and/or induction of MYCN cells were analysed by propidium iodide staining for the presence of hypodiploid (apoptotic) nuclei (Nicoletti et al., 1991) . IFNg treatment alone did not result in fragmentation within the ®rst 48 h, and only 10% of the cells contained fragmented DNA after 96 h ( Figure 1B) . In contrast, IFNg in concert with MycN induced fragmentation in 20% of the cells after 48 h, and almost 50% of the cells had a sub-diploid DNA content after 96 h ( Figure 1B) . We conclude that MycN and IFNg eciently cooperate to induce apoptosis in neuroblastomas.
Induction of cell death by IFNg and MycN requires caspase activity
Caspases are a family of cysteine proteases involved in multiple apoptotic pathways (reviewed in Fraser and Evan, 1996) . To determine if caspases play a role in MycN and IFNg mediated cell death, the cleavage of poly (ADP) ribose polymerase (PARP), a substrate of caspases with unknown function in apoptotis, was analysed by immunoblotting. Substantial levels of the 85 kD PARP fragment, which is generated by caspases through proteolytic cleavage of a 116 kD precursor, were detected in MYCN + cells treated with IFNg ( Figure 2a ). Minute amounts of the 85 kD cleavage product were detected in MYCN + cells in the absence of IFNg or in MYCN 7 cells treated with IFNg (data not shown). PARP cleavage was not observed in control cells that were neither induced to express MYCN nor treated with IFNg.
Caspase-3, known to cleave PARP, is a 17 kD protein generated by proteolytic cleavage of the 32 kD pro-caspase-3 (also named CPP32/Yama/apopain; Lazebnik et al., 1994) . Immunoblotting was used to determine whether MycN and IFNg triggered cell death is associated with cleavage of pro-caspase-3. The level of pro-caspase-3 declined within 48 h of treatment with IFNg and/or induction of MYCN, indicating generation of the active form ( Figure 2a) . However, the decline of pro-caspase-3 was most pronounced in cells that were treated with IFNg and simultaneously expressed MYCN, consistent with the previous observations.
To further determine the role of caspases in MycN and IFNg induced cell death, ZVAD-fmk, a broad range inhibitor of caspases, was added to cells exposed to IFNg in the presence or absence of MYCN. Cell death was monitored by propidium iodide staining of nuclei followed¯ow cytometry. Cell death was almost completely blocked in the presence of 60 mM ZVADfmk ( Figure 2b ).
MycN and IFNg regulate death receptor signaling pathways
CD95 belongs to a family of cell surface receptors that trigger cell death upon binding of the ligand CD95-L (Trauth et al., 1989) . To determine whether the CD95 death signaling system plays a role in MycN and IFNg mediated apoptosis we analysed CD95 cell surface expression in response to IFNg or to induction of MYCN expression by FACS analysis. IFNg resulted in a twofold increase of CD95 cell surface expression that was not further increased by MycN (Figure 3a) . IFNg did not in¯uence CD95-L expression as judged by Western-blotting using a CD95-L speci®c antibody (data not shown). In some experiments we observed a small increase in the amount of CD95-L in response to MYCN expression (data not shown). Further experiments will be necessary to clarify whether MycN regulates the level of CD95-L. We next analysed whether MYCN expression could in¯uence CD95 mediated apoptosis. Cells were treated with the monoclonal antibody anti-APO-1, which upon binding to the CD95 receptor mimicks CD95-L and initiates a signal cascade that eventually leads to apoptosis (Trauth et al., 1989) . After 72 h cells were harvested and the extent of apoptosis was measured by FACS analysis of hypodiploid nuclei with propidium iodide. MYCN + cells showed an almost threefold increase in the proportion of cells undergoing anti-APO-1 triggered apoptosis (Figure 3b ). MYCN expression likewise increased the sensitivity for apoptosis triggered by TRAIL and TNFa ( Figure  3b ). When cells were treated with IFNg in combination with either anti-APO-1 or TNFa the percentage of dying cells was higher compared to anti-APO-1 or TNFa alone, regardless of MYCN expression (data not shown). Thus, IFNg and MycN cooperate by increasing CD95 cell surface expression and enhancing the susceptibility for the CD95 death signal.
Induction of genes in response to IFNg and MycN
Several IFNg and Myc activated genes play a role in the induction and/or execution of apoptosis including the IFNg immediate early gene IRF1, which encodes the interferon regulatory transcription factor (IRF)-1 (Tanaka et al., 1994; Tamura et al., 1995) and the Myc induced ornithine decarboxylase gene (Packham and Cleveland, 1994) . We previously showed induction of ornithine decarboxylase expression by MycN in neuroblastoma cells (Lutz et al., 1996) . Here, we used quantitative RT ± PCR to show that the expression level of IRF1 in cells exposed to IFNg was elevated sixfold in of MycN + and 20-fold in MycN 7 cells (Figure 4) . The MYCN mRNA level, which was determined as a control, was increased about 20-fold 72 h after induction of MYCN (Figure 4) , which is in agreement with our previous data (Lutz et al., 1996) .
ISGF3g, which encodes the DNA binding subunit of the heteromeric transcription factor ISGF3 is another interferon inducible gene (Levy et al., 1990) . Murine ISGF3g was recently shown to be induced not only by IFNg but also by c-Myc (Weihua et al., 1997) . RT ± PCR revealed that ISGF3g mRNA was increased threefold in response to IFNg (Figure 4 ). ISGF3g expression did not change in response to MycN ( Figure  4 ). The expression of APAF1, the recently cloned mammalian homologue of the C. elegans ced-4 cell death gene (Zou et al., 1997) , and of PITSLRE b1 (also named CDC2L1), which encodes a protein kinase involved in apoptosis of Chinese hamster ovary cells (Lahti et al., 1994 (Lahti et al., , 1995 remained unchanged in response to either IFNg or MycN or both (Figure 4) . The possible role of IRF-1 and ISGF3g in the IFNg and MycN triggered apoptosis of neuroblastoma cells should be determined further in future experiments.
IFNg and MYCN regulate pro-apoptotic members of the BCL2 family Bcl-2 and related proteins constitute an apoptosis regulatory network upstream of the caspases (Chinnaiyan et al., 1996; for a review see Kroemer, 1997) . To test whether cooperation between MycN and IFNg would aect the status of the Bcl-2 network, we FACS analysis of CD95 cell surface expression after 48 h of treatment with 1000 U/ml IFNg and/or induction of MYCN. The background¯uorescence obtained with a control antibody is also shown (b) Extent of cell death in response to various death ligands is dependent on MYCN expression. Cells were treated with 1 mg/ml anti-Apo-1, 10 mg/ml TRAIL, or 1 ng/ml TNFa in the presence (black bars) or absence (white bars) of MYCN expression for 72 h. DNA fragmentation was determined by staining cells with propidium iodide and measuring fragmentation in a¯ow cytometer. Speci®c cell death is given as the percentage of apoptotic cells after subtraction of the percentage of cells spontaneously undergoing apoptosis in control cultures determined the expression of the anti-apoptotic BCL2 and of the three pro-apoptotic BCL2 family members BAK, BAD and BAX-alpha. The mRNA levels of BCL2, BAD and BAX-alpha remained unchanged after 72 h of treatment with IFNg and/or expression of MYCN (Figure 5a ). BAK mRNA level was increased threefold by IFNg (Figure 5a ). Neither MycN nor IFNg individually changed the level of Bax protein (Figure 5b ). However, in combination MycN and IFNg led to an increase of Bax protein suggesting that they cooperate to regulate Bax at a posttranscriptional level (Figure 5b ). Together, MycN and IFNg appear to shift the balance of Bcl-2 related pro-and anti-apoptotic proteins towards death promoting proteins like Bak and Bax thereby increasing the propensity of a cell to undergo cell death in response to apoptotic signals.
Discussion
We have analysed the potential of MycN and IFNg, alone or in combination, to in¯uence the cell death decision of neuroblastoma cells. We show that conditional expression of MYCN or treatment with IFNg barely in¯uence the survival of neuroblastoma cells when acting alone. In contrast, we observed massive cell death when MycN and IFNg act in concert suggesting a strong cooperation between the cytokine and the transcription factor. MycN and IFNg triggered cell death showed major hallmarks of apoptosis as it was accompanied by DNA fragmentation and required caspase activity. Our ®nding of pro-caspase-3 activation in the course of MycN and IFNg triggered apoptosis provides a potential explanation for the recently reported observation of higher levels of procaspase-3 in favorable neuroblastomas (Nakagawara et al., 1997) .
Our failure to observe substantial cell death following conditional expression of MYCN in growth factor deprived cells does not necessarily distinguish MYCN from the closely related MYC whose overexpression in several systems has been observed to drive cells into S-phase in the absence of growth signals and to trigger apoptosis at the same time (reviewed in Henriksson and LuÈ scher, 1996) . MYC expression has been found to implement cells with programs for both proliferation and cell death. Myc triggered apoptosis has been interpreted as a safeguard mechanism that allows the elimination of cells sensing two con¯icting signals, expression of the proliferation stimulating MYC and at the same time the absence of growth signals in the cellular environment (Evan and Littlewood, 1993) . We have shown previously that ectopic expression of MYCN is not sucient to drive growth factor deprived neuroblastoma cells into S-phase (Lutz et al., 1996) . Consequently, a con¯ict of signals is not generated, which would explain the lack of apoptosis.
Participants in MYCN/IFNg apoptosis of neuroblastoma cells
The cooperation between IFNg and MycN appears complex. It included both a modulation of death signaling through the death receptor CD95 as well as an increase of Bcl-2 related proteins promoting apoptosis. Cooperation at the level of CD95 involved as one element the IFNg mediated increase of cell surface expression of CD95, which has previously also been seen in other cell types (Friesen et al., 1996; Sato et al., 1997; Ossina et al., 1997) . The other element was the MycN mediated increase of cellular susceptibility towards the death signal that is initiated from CD95. As shown very recently, c-Myc sensitizes rat ®broblasts to CD95 mediated apoptosis (Hueber et al., 1997) .
Cooperation through the apoptosis-regulatory network of Bcl-2 related proteins is best demonstrated by the fact that IFNg only in concert with MycN increased the amount of Bax protein. IFNg alone induced expression of BAK while MycN alone did not transcriptionally activate any of the BCL2 related genes tested including BAX, in spite of the presence of several potential binding sites for Myc proteins in the BAX promoter (Miyashita and Reed, 1995) . The increased Bax level therefore must result from a posttranscriptional regulatory mechanism. MycN in combination with the anti-cancer drug doxorubicin also increases the amount of Bax in neuroblastoma cells (S Fulda and K-M Debatin, unpublished observations). The role of Bax as a positive regulator of apoptosis is well established (Oltvai et al., 1993) . It is therefore reasonable to assume that the enhanced level of Bax as a consequence of MYCN expression and simultaneous treatment with IFNg is a major factor in triggering apoptosis. The induction of BAK expression by IFNg may further increase the propensity of a cell to undergo apoptosis. Overexpression of BAX-alpha has been found to restore the sensitivity to dierent apoptotic stimuli including serum starvation and CD95-L triggered apoptosis (Bargou et al., 1996) . Thus, the increased Bax level in response to IFNg and MycN may be responsible for the enhanced susceptibility towards anti-APO-1 triggered death.
MYCN mediates susceptibility for apoptosis
MycN not only cooperated with IFNg and increased the cellular response to CD95 mediated death signals, but also enhanced the cellular susceptibility towards various additional death signals including the death ligands TRAIL and TNFa (Wiley et al., 1995; Pan et al., 1997; Sheridan et al., 1997) . Overexpression of MYC has been found to increase the cytotoxicity of TNFa in rat ®broblasts (Klefstrom et al., 1994; JaÈ nicke et al., 1994 ). It appears that Myc proteins can increase the cellular response towards various death signals, much in the same way they potentiate the eect of multiple growth factors. The death signals provided by TNFa, anti-APO-1/CD95-L and TRAIL, respectively, are transmitted into the cell by death receptors that use overlapping signaling pathways (reviewed by Fraser and Evan, 1996) . This could explain why all of these death signals are modulated by MycN. In contrast, signaling by the IFNg receptor proceeds through a completely dierent pathway (for a review see Bach et al., 1997) . It therefore would seem unlikely that MycN targets speci®c components of these diverse signal transduction pathways to regulate the responses to IFNg or other death signals. MycN may rather regulate the overall propensity of a cell to initiate cell death regardless of the death signal involved. Since the transcription factor IRF-1 is required for apoptosis in several cell types (Tanaka et al., 1994; Tamura et al., 1995) , it may also mediate the IFNg death signal in neuroblastoma cells. The weaker induction of IRF1 (and also BAK and ISGF3g) by IFNg in cells expressing MYCN compared to cells without MYCN expression remains unexplained.`Technical knock out' has identi®ed several genes that beside IRF1 are required for IFNg triggered apoptosis (Deiss and Kimchi, 1991; Levy-Strumpf et al., 1997) .
Clinical perspectives?
The observations made in this study entail several considerations of clinical relevance. The CD95 system is involved in drug-induced apoptosis in neuroblastoma cells, and Bak, at least in lymphoid cells, accelerates chemotherapy-induced apoptosis (Fulda et al., 1997; Simonian et al., 1997) . By up-regulating both CD95 and BAK IFNg may increase the susceptibility of neuroblastoma cells to death triggered by anti-cancer drugs, providing a rationale for employing IFNg in the treatment of neuroblastomas. The changes in gene expression described here may constitute part of a general cellular response to IFNg as up-regulation of CD95 and BAK expression by IFNg was recently found in the human colon adenocarcinoma cell line HAT-29 (Ossina et al., 1997) . Since IFNg cooperates with MycN to trigger apoptosis those patients with tumors showing strong MYCN expression as a result of gene ampli®cation may bene®t particularily from IFNg based therapeutical regimens.
Materials and methods
Cell culture and treatment with cytokines, antibodies and caspase inhibitor
The generation, characterization and culture of the MYCN inducible cell line SH-EP Tet-21/N has been described (Lutz et al., 1996) . Induction of MYCN expression by removal of tetracycline from the growth medium and addition of recombinant human IFNg (Boehringer, Mannheim) at 1000 U/ml or recombinant human TNFa at 1 ng/ml (BIOTREND, KoÈ ln, Germany) were carried out shortly before cultures reached con¯uence as apoptosis was most pronounced in con¯uent cultures. The broad range caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(Omethyl-)¯uoromethylketone, ZVAD-fmk (Enzyme Systems Products, Dublin, CA), was used at a concentration of 60 mM. Anti-APO-1 was added at 1 mg/ml (Trauth et al., 1989) and recombinant TRAIL puri®ed from Pichia pastoris at 10 mg/ml (Jeremias J, Herr I, BoÈ hler T, Debatin K-M. TRAIL-induced apoptosis in T-cells, submitted).
DNA fragmentation assays
For visualization of DNA fragmentation by gel electrophoresis both adherent and non-adherent cells were collected from a 10 cm cell culture dish and lysed with 200 ml lysis buer (20 mM Tris pH 7.4/1 mM EDTA/0.4% Triton X-100) for 5 min on ice. After clearing the lysate by centrifugation nucleic acids were extracted with phenol/ chloroform, precipitated with ethanol, resuspended in TE, treated with 300 mg/ml RNase A, fractionated on a 1.5% agarose gel and stained with ethidium bromide.
For determination of the fraction of cells with DNA fragmentation nuclei prepared from cells grown in 24-well microtiter plates were stained with propidium iodide and subsequently analysed by¯ow cytometry (Nicolleti et al., 1991) . Ten thousand events were acquired for each sample using a FACScan (Becton Dickinson, Heidelberg, Germany) and CELLQuest software. The extent of cell death is given as the percentage of nuclei with a subdiploid amount of DNA as a consequence of DNA-fragmentation.
Western blotting
Preparation of cell lysates and determination of protein concentration were performed as described (Lutz et al., 1996) . For Western-blotting 15 mg of protein were separated on an SDS-polyacrylamide gel and blotted onto nitrocellulose membranes (Schleicher & Schuell). Proteins were visualized using the ECL detection system (Amersham). The following antibodies were used: anti MycN monoclonal antibody (Wenzel et al., 1991) , anti Bax polyclonal antibody Ab-1 (Calbiochem), anti-PARP polyclonal antibody (Boehringer, Mannheim), anti CPP-32 monoclonal antibody (Signal Transduction Laboratories, Lexington, KY).
FACS quanti®cation of CD95 cell surface expression 10 6 cells were harvested, washed in PBS/1% BSA and incubated successively with 1 mg/ml anti-APO-1 (CD95) monoclonal antibody (Trauth et al., 1989) and with an phycoerythrin coupled goat anti-mouse secondary antibody (Immunotech, Hamburg, Germany) for 45 min at 48C each. FII23 antibody (Trauth et al., 1989) was used as an isotype matched non-binding antibody to control for unspeci®c binding.
Gene expression analysis by RT ± PCR
PCR primers (Table 1) were designed based on sequences retrieved from the EMBL data base. Total RNA was isolated from cells using guanidinium thiocyanate (Chomczynski and Sacchi, 1987) , treated with DNase I, and extracted with phenol/chloroform. All subsequent enzymatic reactions were performed with all samples at the same time using master mixes. 1 mg of RNA was used for cDNA ®rst strand synthesis in a 20 ml reaction (1st strand cDNA synthesis kit for RT ± PCR; Boehringer, Mannheim). 1 ml of this reaction (corresponding to 50 ng of reverse transcribed RNA) was used as template in the polymerase chain reaction which was prepared on ice and contained in a volume of 50 ml 1.5 mM MgCl 2 , 200 mM of each dNTP, 50 pmol of each primer, 5 ± 25 pmol of primers for the co-ampli®cation of the genes encoding ribosomal protein S14, glycerolaldehyde-3-phosphate dehydrogenase (GAPDH) or dihydrofolate reductase (DHFR), which served as an internal control and 1 U of Taq DNA Polymerase (Promega). For ampli®cation of the MYCN PCR fragment with a GC content of 75% the Advantage-GC cDNA PCR kit (Clontech Laboratories) was used. PCR conditions were 958C for 3 min followed by 958C, 628C, and 748C for 1 min each in a Biometra thermal cycler. For the initial testing of primers and primer combinations 30 cycles were performed. For quantitative PCR the reaction was terminated after 18 or 21 cycles before non linear conditions were reached. 10 ml of each reaction was seperated on a 1.5% agarose gel, blotted onto Hybond N + (Amersham), and sequentially hybridized to 32 P-labeled probes. Radioactive signals were quantitated using a model 400 phosphorimager (Molecular Dynamics) and normalized to the signal of the co-ampli®ed gene. 
